EX-4.2 7 d360404dex42.htm EX-4.2 FULGENT THERAPEUTICS LLC INVESTOR’S RIGHTS AGREEMENT Dated as of May 17, 2016 PageInvestor's Rights Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 Jurisdiction
FULGENT THERAPEUTICS LLC INVESTOR’S RIGHTS AGREEMENT Dated as of May 17, 2016Investor's Rights Agreement • September 2nd, 2016 • Fulgent Genetics, Inc. • Services-medical laboratories • California
Contract Type FiledSeptember 2nd, 2016 Company Industry JurisdictionTHIS INVESTOR’S RIGHTS AGREEMENT (this “Agreement”) is entered into effective as of May 17, 2016, by and between Fulgent Therapeutics LLC, a California limited liability company (the “Company”), and Xi Long USA, Inc., a Delaware corporation (the “Investor”). The Company and the Investor are sometimes collectively referred to herein as the “Parties” and individually as a “Party.”